Benitec Biopharma Analyst Ratings
Benitec Biopharma Analyst Ratings
While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a maintained with a price target of $4.00 to $6.00. The current price Benitec Biopharma (BNTC) is trading at is $3.15, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/26/2023 | 90.48% | JMP Securities | $4 → $6 | Maintains | Market Outperform |
| 06/26/2023 | 26.98% | JMP Securities | → $4 | Reiterates | Market Outperform → Market Outperform |
| 05/18/2023 | 26.98% | JMP Securities | $4 → $4 | Reiterates | Market Outperform → Market Outperform |
| 10/18/2022 | 26.98% | JMP Securities | → $4 | Initiates Coverage On | → Market Outperform |
| 09/23/2022 | 26.98% | HC Wainwright & Co. | $10 → $4 | Maintains | Buy |
| 02/17/2022 | 217.46% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 10/05/2020 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/26/2023 | 90.48% | JMP證券 | $4→$6 | 維護 | 市場表現強於大盤 |
| 2023/06/26 | 26.98% | JMP證券 | →$4 | 重申 | 市場表現優於→市場表現 |
| 2023年05月18日 | 26.98% | JMP證券 | $4→$4 | 重申 | 市場表現優於→市場表現 |
| 10/18/2022 | 26.98% | JMP證券 | →$4 | 開始承保 | →市場跑贏大盤 |
| 09/23/2022 | 26.98% | HC Wainwright公司 | $10→$4 | 維護 | 買 |
| 02/17/2022 | 217.46% | HC Wainwright公司 | →$10 | 開始承保 | →購買 |
| 10/05/2020 | - | 拉登堡·塔爾曼 | 評級下調 | 購買→中性 |
What is the target price for Benitec Biopharma (BNTC)?
Benitec Biophma(BNTC)的目標價是多少？
The latest price target for Benitec Biopharma (NASDAQ: BNTC) was reported by JMP Securities on September 26, 2023. The analyst firm set a price target for $6.00 expecting BNTC to rise to within 12 months (a possible 90.48% upside). 4 analyst firms have reported ratings in the last year.
摩根大通證券於2023年9月26日報道了貝尼泰克生物製藥(納斯達克：BNTC)的最新目標價。這家分析公司將目標價定為6.00美元，預計BNTC將在12個月內上漲至90.48%。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Benitec Biopharma (BNTC)?
Benitec Biophma(BNTC)的最新分析師評級是多少？
The latest analyst rating for Benitec Biopharma (NASDAQ: BNTC) was provided by JMP Securities, and Benitec Biopharma maintained their market outperform rating.
納斯達克(JMP Securities)對貝尼泰克生物製藥(BNTC)的最新分析師評級是由摩根大通證券提供的，貝尼泰克生物製藥維持其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Benitec Biopharma (BNTC)?
Benitec Biophma(BNTC)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Benitec Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Benitec Biopharma was filed on September 26, 2023 so you should expect the next rating to be made available sometime around September 26, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Benitec Biophma的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Benitec Biophma的上一次評級是在2023年9月26日提交的，因此您應該預計下一次評級將在2024年9月26日左右的某個時候提供。
Is the Analyst Rating Benitec Biopharma (BNTC) correct?
分析師評級Benitec Biophma(BNTC)正確嗎？
While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a maintained with a price target of $4.00 to $6.00. The current price Benitec Biopharma (BNTC) is trading at is $3.15, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Benitec Biophma(BNTC)評級維持不變，目標價在4.00美元至6.00美元之間。Benitec Biophma目前的交易價格為3.15美元，超出了分析師的預測區間。
